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Objective: Temporal macula thinning has been reported in sickle cell patients, but it remains unclear if there is a difference between
HbSS and HbSC genotypes. We aimed to quantitatively compare macular thickness between eyes with HbSS and HbSC
genotype.
Design: Retrospective descriptive study.
Methods: Consecutive patients seen over a 5.5-year period in the Ophthalmology Department at St Thomas’ Hospital, London,
were identified. Macular optical coherence tomography images were retrospectively analyzed. The retinal thickness in all
9 subfields of the Early Treatment Diabetic Retinopathy Study (ETDRS) grid was compared between HbSS and HbSC eyes. Right
eyes and left eyes were analyzed independently, as well as averaged measurements from both eyes. Comparison was made
between the 2 genotypes, adjusting for age and sex, and for multiple testing. Scans were excluded in cases of poor fixation or
ocular comorbidity affecting retinal thickness.
Results: 132 HbSC and 120 HbSS patients were identified. Scans from 166 right and 153 left eyes were included (with
approximately equal numbers of HbSS and HbSC genotypes). Mean retinal thickness was lower in HbSS eyes compared with
HbSC eyes in all subfields of the ETDRS grid, but in most subfields the difference was o10 microns. Differences reached
statistical significance for outer superior, inferior, and temporal subfields and the inner temporal subfield (p o 0.05).
Conclusion: Although the HbSC genotype is more strongly associated with proliferative retinopathy, HbSS patients had on average
more macular thinning.& 2017 Canadian
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ISSN 0008-4182/1Sickle cell disease is caused by abnormal hemoglobin in
red blood cells causing red blood cells to assume a rigid
sickle shape under certain circumstances, such as low
oxygen concentration. The sickle-shaped blood cells can
block capillaries, causing ischemia and end organ damage.1
The 2 main variants of sickle cell disease are HbSS and
HbSC, determined by the mutated allele present. HbSS is
caused by the presence of 2 copies of the mutated
hemoglobin S (HbS) allele. The mutation results in a
glutamic acid being substituted by valine at position 6 on
the beta-globin chain.2 The mutation causes instability of
the hemoglobin S molecules, causing red cells to assume a
sickle-shaped conformation rather than a normal bicon-
cave disc when metabolically stressed.
.In the other major variant, HbSC, there is 1 HbS allele
and another hemoglobin C (HbC) allele. The HbC allele
is caused by substitution of a glutamic acid residue to a
lysine residue at position 6 on the beta-globin chain. The
HbC molecule is more stable than HbS; therefore,
the HbSC genotype does not cause as much sickling as
the HbSS genotype. As a result, HbSC patients experience
fewer systemic vaso-occlusive events. However, it is well
established that sickle cell patients with the HbSC
genotype have a greater prevalence of proliferative retin-
opathy compared with sickle cell patients of HbSS
genotype.3Ophthalmological Society.
ier Inc. All rights reserved.
016/j.jcjo.2017.10.006
7Previous reports have shown that macular thinning
is a common ﬁnding in sickle cell patients.4,5
Our study was undertaken to establish whether there is a
difference in macular thickness between sickle cell
patients with HbSS and HbSC genotypes. Mathew
et al.6 reported that macular thinning was associated more
with HbSS compared with HbSC eyes but were cautious
in making any conclusions because of an unequal distri-
bution of the 2 genotypes in their cohort. Their results
were based on qualitative analysis of the presence of
temporal thinning, whereas in our study, we used
quantitative retinal thickness measurements, obtained
with spectral domain optical coherence tomography
(OCT).MATERIAL AND METHODS
Consecutive HbSS and HbSC patients seen in the
retinal service at St Thomas’ Hospital, London, over a
5.5 year period were identiﬁed from the electronic patient
record. Their macular OCT images were retrospectively
reviewed. Scans that were poorly centered or from patients
with other ocular comorbidities that could affect retinal
thickness (such as an epiretinal membrane or diabetic
maculopathy) were excluded. The most recent eligible
scans were included.CAN J OPHTHALMOL—VOL. ], NO. ], ] 2017 1
Table 1—Demographics of HbSC and HbSS patients









Mean age ± SD (years) 41 ± 12 37 ± 11 42 ± 12 37 ± 11
Sex, n (%)
Female 58 (70) 57 (69) 50 (68) 55 (70)
Male 25 (30) 26 (31) 24 (32) 24 (30)
Retinal thickness in sickle cell patients—Lim et al.Macular OCT scans were obtained using a Topcon 3D
OCT-2000 machine or 3D-OCT 1000 (Topcon Medical
Systems, Oakland, N.J.); standard three-dimensional mac-
ula scans, 6.0 × 6.0 mm wide and 512 × 128 resolution,
were analysed. The retinal thickness in all 9 sectors of the
Early Treatment Diabetic Retinopathy Study (ETDRS)
grid was recorded from the Topcon OCT viewing software
(Fig. 1), after establishing that there were no segmentation
errors. Measurements from the left and right eyes were then
analyzed independently. Each reading was taken by
1 of 3 doctors involved in the data acquisition in this study.
The mean retinal thickness in each sector of the
ETDRS grid was calculated for HbSS and HbSC eyes.
The values obtained for right eyes and left eyes were
initially analyzed separately, and then averaged data from
both eyes were included per patient (unless only 1 eye was
eligible). Thicknesses were compared between the HbSC
and HbSS groups (unpaired t test). The results were then
adjusted for age and sex (by performing a regression on age
and sex and using the residuals for the t test). Those
p values that emerged as signiﬁcant (p o 0.05) were then
corrected for multiple testing by using a permutation
procedure (label-swapping with empirical p values com-
pared with p values from 1000 randomly permuted
t tests).
This study was retrospective and was conducted by the
clinical care team, with subsequent analysis of anonymized
data. Formal ethical approval was not required, asFig. 1—Examples of macular subfield thicknesses and OCT sc
horizontal OCT scan through the foveal center (right panel)
B, Corresponding images from a patient with HbSS genotype
patient with more marked temporal thinning.
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& Development Department.RESULTS
132 HbSC and 120 HbSS patients were identiﬁed. The
right eyes of 35 HbSC patients and 30 HbSS were
excluded because a macula OCT was unavailable or
because of other retinal comorbidities that could affect
macular thickness. An additional 14 right eyes of HbSC
patients and 7 right eyes of HbSS patients were excluded
because the scan, and therefore the ETDRS grid, was not
adequately centered on the fovea. In total, the right eyes of
83 HbSC and 83 HbSS patients were included in the
analysis. Proportions of right eyes excluded were similar
for both genotypes (p ¼ 0.29).
The left eyes of 39 HbSC patients and 27 HbSS
patients were excluded because a macula OCT was
unavailable or because of other retinal comorbidities thatans from 3 patients. A, Subfield thicknesses (left panel) and
for an HbSC patient with minimal or no macular thinning.
with mild temporal thinning. C, Images from another HbSS
Table 2—Macular thickness of HbSC and HbSS eyes in all subfields of the ETDRS grid
Subfield on ETDRS
grid





















Central 207 (24) 202 (20) 0.175 206 (22) 202 (21) 0.200
Inner superior 289 (24) 283 (29) 0.131 288 (22) 283 (31) 0.297
Inner nasal 289 (20) 285 (25) 0.322 290 (20) 288 (23) 0.562
Inner inferior 286 (26) 281 (31) 0.290 287 (21) 283 (26) 0.229
Inner temporal 275 (23) 266 (33) 0.039* 271 (21) 264 (38) 0.124
Outer superior 263 (19) 256 (18) 0.018* 263 (18) 259 (24) 0.329
Outer nasal 276 (19) 271 (20) 0.092 274 (20) 272 (22) 0.473
Outer inferior 256 (22) 250 (18) 0.075 255 (17) 250 (20) 0.107
Outer temporal 240 (24) 228 (26) 0.005* 241 (19) 233 (26) 0.022*
ETDRS, Early Treatment Diabetic Retinopathy Study.
Right and left eye measurements were not combined.
*Statistically significant difference between the 2 genotypes (p o 0.05).
Retinal thickness in sickle cell patients—Lim et al.could affect macular thickness. An additional 19 left eyes
of HbSC patients and 14 left eyes of HbSS patients were
excluded because the ETDRS grid was not centered on the
fovea. Hence, the left eyes of 74 HbSC and 79 HbSS
patients were included in the analysis. Proportions of left
eyes excluded were similar for both genotypes (p ¼ 0.11).
Patient demographics are shown in Table 1. Sex
distributions were similar for the 2 genotypes, but HbSS
patients were signiﬁcantly younger (p ¼ 0.03).
Figure 1 shows examples of macular OCT imaging
from a patient with HbSC genotype and 2 patients with
HbSS genotype.
Table 2 compares the macular thickness in all 9 subﬁelds
of the ETDRS grid for HbSS and HbSC patients. The
right eyes and left eyes were analyzed separately.
Table 3 compares the macular thickness in all 9 subﬁelds
of the ETDRS grid for HbSS and HbSC patients, with the
average of right and left eye measurements taken for each
patient if both were available. Right-hand columns give
raw p values (unpaired t test) and after adjustment for age
and sex. Those p values found to be signiﬁcant after the
latter adjustment were corrected for multiple testing in the
ﬁnal column.Table 3—Comparison of retinal thickness measurements between
both eyes (unless only 1 eye eligible for inclusion)
Mean (SD) Retinal Thickness (microns)
ETDRS subfield HbSC (n ¼ 91) HbSS (n ¼ 93)
Central 206 (23) 203 (20)
Inner superior 288 (22) 284 (28)
Inner nasal 289 (19) 287 (23)
Inner inferior 286 (22) 282 (24)
Inner temporal 272 (22) 266 (32)
Outer superior 262 (17) 258 (20)
Outer nasal 274 (19) 271 (20)
Outer inferior 255 (20) 250 (17)
Outer temporal 240 (21) 230 (24)
ETDRS, Early Treatment Diabetic Retinopathy Study; NA, not applicable.
p values are from unpaired t test. The correction for multiple testing was only applied to param
*p o 0.05 was taken as significant.The results show that the average retinal thickness in all
subﬁelds of the ETDRS grid were lower in HbSS eyes
compared with HbSC eyes. The differences, although small,
were statistically signiﬁcant in the outer temporal subﬁeld in
both right and left eyes. After averaging data from both
eyes, correcting for age, sex, and multiple testing, the
differences were signiﬁcant for all outer subﬁelds (other
than the nasal) and for the inner temporal subﬁeld.DISCUSSION
In this study, we retrospectively reviewed the macular
OCT scans of a large consecutive cohort of patients with
sickle cell disease and found that although central macular
thickness measurements are similar in both HbSS and
HbSC genotypes, HbSS patients had on average greater
macular thinning for all macular subﬁelds. This reached
statistical signiﬁcance in the superior, inferior, and tem-
poral outer subﬁelds and the inner temporal subﬁeld.
These results are consistent with the previously sug-
gested idea that HbSS patients are more likely to have
macular thinning,6 particularly temporally, compared with
those with HbSC. Our ﬁndings are consistent withHbSS and HbSC genotypes with measurements averaged from















eters with significant p values (after adjusting for age and sex).
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Retinal thickness in sickle cell patients—Lim et al.different patterns of sickle cell retinopathy in HbSS and
HbSC patients. Inner retinal loss in individuals with sickle
cell disease has previously been explained by retinal
ischemia caused by occlusion of the retinal vasculature.7,8
Emerging data from OCT angiographic studies conﬁrm
the poor perifoveal circulation and suggest that ﬂuorescein
angiography may not be as sensitive in detecting poor
perfusion.9 HbSS patients are known to have more
systemic vaso-occlusive events, but they paradoxically have
a milder phenotype in the peripheral retina from prolifer-
ative sickle retinopathy. Although HbSC patients have
greater risk of proliferative retinopathy, in a recent study,
HbSC genotype was not found to be a risk factor for visual
loss. This may be explained in part by HbSS patients
having more macular pathology contributing to sight loss,
which would be supported by the ﬁndings of the present
study.10 Using OCT angiography, Han et al. found lower
density of deep capillary plexus at the temporal macula in
HBSC eyes but no statistical difference in mean foveal
nonﬂow area between HBSS and HBSC eyes.11
The pattern of subﬁeld thinning is intriguing. Vessel
occlusion leading to macular thinning has been shown to
mainly affect the region temporal to the fovea as the
temporal macular vasculature ends in the horizontal raphe
acting like terminal vessels.12 The subﬁelds corresponding
to nonsigniﬁcant p values in Table 3 might show
signiﬁcant differences with a larger sample. If the 3-micron
difference in central subﬁelds were signiﬁcant, approxi-
mately 700 or more patients would be required in each
group to detect this with 80% power (although fewer
individuals may be needed if the cohorts were age-matched
or parameters age-adjusted). However, it is debatable
whether such a small difference would be of clinical
signiﬁcance.
The macular thinning in HbSS has been associated with
reduced retinal sensitivity, albeit with preserved central
Snellen visual acuity.13 The disparity between the macula
and the peripheral retina, with possibly more pronounced
macular changes in HbSS, yet more peripheral proliferative
changes in HbSC, remains difﬁcult to explain. Hannemann
et al. showed that HBSC red cells sickle via a slightly
different mechanism from HBSS red cells involving different
ion channels causing red cell dehydration.14 Different
metabolic conditions in the peripheral retina and differences
in vascular architecture with rates of blood ﬂow might cause
differential mechanisms, or effects, of sickling in the 2 gen-
otypes. It is also possible that retinal thinning is still more
pronounced in HbSS patients in the periphery, and the
mechanism for development of proliferative retinopathy may
not associate strongly with retinal thinning.
Some limitations of the present study deserve mention.
The study was retrospective, and not all patients had available
scans. The cohort of patients was those seen in a retina clinic,
and it is possible that those with visual impairment would be
overrepresented. However, because patients are referred
routinely from hematology departments for annual eye4 CAN J OPHTHALMOL—VOL. ], NO. ], ] 2017screening, the majority were asymptomatic. Also, the mean
age was different in the 2 cohorts: the HbSS patients were
younger. However, retinal thickness (in noncentral subﬁelds)
declines with age,15 so the ﬁnding of reduced thickness in the
HbSS patients would not appear to be attributable simply to
the age difference because it is in the opposite direction;
indeed, the p values became more signiﬁcant after correction
for age. We had to exclude a large number of eyes because of
other pathologies that could affect macular thickness, such as
epiretinal membranes, cystoid macular edema, drusen, mac-
ular hole, and previous retinal detachment surgery.
In conclusion, in this study we present data suggesting
that on average HbSS patients had greater macular
thinning than HbSC patients, especially in the outer
macular subﬁelds. It would also be interesting to look at
retinal thickness of the peripheral retina outside the
ETDRS grid, and emerging wider ﬁeld OCT technologies
may help answer the many remaining questions.REFERENCES
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